The CMA's acceptance in principle removes a key regulatory overhang and keeps the NCR Atleos deal on schedule. Monitor for a definitive buyer for NoteMachineTestLink UK and any further regulatory approvals needed before the expected Q1 2027 close.
Price Chart
Executive Summary
Brink's announced that the UK's Competition and Markets Authority (CMA) has accepted in principle its proposed remedy — the divestiture of NoteMachineTestLink UK — to avoid a Phase 2 investigation into its pending acquisition of NCR Atleos. The acquisition remains on track to close early in Q1 2027, and the divestiture does not impact the expected $200 million in annual run-rate cost synergies within three years of closing.
Key Facts
- CMA accepted in principle Brink's proposed remedy of divesting NoteMachineTestLink UK to avoid a Phase 2 referral.
- Acquisition of NCR Atleos remains on track to close early in Q1 2027.
- The divestiture does not impact the expected $200 million in annual run-rate cost synergies within three years of closing.
- Sale process for NoteMachineTestLink UK is progressing with multiple prospective buyers.
Financial Impact
The divestiture was contemplated in previously disclosed financial metrics and does not affect the $200 million annual run-rate cost synergy target. No financial terms of the divestiture were disclosed.
Risk Factors
- Failure to find a suitable buyer for NoteMachineTestLink UK could still trigger a Phase 2 investigation.
- Integration risks and the substantial indebtedness Brink's will incur to finance the transaction could pressure the balance sheet.
- General economic conditions or other regulatory hurdles could delay or prevent closing.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000078890-26-000063 |
| Exhibit: exhibit991pressrelease2026.htm | 0000078890-26-000063 |
| Document: 0000078890-26-000063-index-headers.html | 0000078890-26-000063 |
| Document: 0000078890-26-000063-index.html | 0000078890-26-000063 |
| Document: 0000078890-26-000063.txt | 0000078890-26-000063 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 8-K | $102.36 $104.42 | ▲ +2.01% | ▲ +2.29% | $110.89 (+8.33%) |
Oct 1, 2026 25d ago | Press Release | $99.97 $102.36 | ▲ +2.39% | ▲ +1.09% | $110.89 (+10.92%) |
Sep 30, 2026 26d ago | Press Release | $100.99 $102.07 | ▲ +1.07% | ▼ −0.84% | $110.89 (+9.80%) |
Aug 5, 2026 11w ago | Institutional Cluster | $115.79 $113.96 | ▲ +1.58% | ▲ +1.93% | $110.89 (+4.23%) |
Aug 5, 2026 11w ago | 8-K | $115.79 $113.96 | ▼ −1.58% | ▼ −1.93% | $110.89 (−4.23%) |
Jul 15, 2026 14w ago | Press Release | $111.88 $122.73 | ▲ +9.70% | ▲ +10.68% | $110.89 (−0.88%) |
Jul 10, 2026 15w ago | Press Release | $104.24 $117.77 | ▲ +12.98% | ▲ +13.54% | $110.89 (+6.38%) |
Jun 30, 2026 16w ago | 8-K | $99.00 $103.91 | ▲ +4.96% | ▲ +4.70% | $110.89 (+12.01%) |
Jun 18, 2026 18w ago | 8-K | $97.55 $94.09 | ▼ −3.55% | ▼ −1.48% | $110.89 (+13.68%) |
Jun 2, 2026 20w ago | 8-K | $102.97 $102.57 | ▼ −0.39% | ▲ +2.58% | $110.89 (+7.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers